Cargando…

The Treatment of Arterial Hypertension

Arterial hypertension is the leading cause of death worldwide and is one of the most important public health problems. Arterial hypertension is a major cardiovascular risk factor with an increasing incidence. In this paper we set out to analyze a group of 3050 patients hospitalized between January 2...

Descripción completa

Detalles Bibliográficos
Autores principales: BRAȘOVEANU, AM, CRUCE, R, MOGOANTĂ, L, CÂRLIG, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical University Publishing House Craiova 201
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014987/
https://www.ncbi.nlm.nih.gov/pubmed/32110437
http://dx.doi.org/10.12865/CHSJ.45.04.03
_version_ 1783496744389050368
author BRAȘOVEANU, AM
CRUCE, R
MOGOANTĂ, L
CÂRLIG, V
author_facet BRAȘOVEANU, AM
CRUCE, R
MOGOANTĂ, L
CÂRLIG, V
author_sort BRAȘOVEANU, AM
collection PubMed
description Arterial hypertension is the leading cause of death worldwide and is one of the most important public health problems. Arterial hypertension is a major cardiovascular risk factor with an increasing incidence. In this paper we set out to analyze a group of 3050 patients hospitalized between January 2013 and December 2017 in terms of drug therapy. We found that the majority of patients received drug treatment with a converting-enzyme inhibitor as a monotherapy, and the most common drug association was the association between conversion enzyme inhibitor and calcium channel blocker.
format Online
Article
Text
id pubmed-7014987
institution National Center for Biotechnology Information
language English
publishDate 201
publisher Medical University Publishing House Craiova
record_format MEDLINE/PubMed
spelling pubmed-70149872020-02-27 The Treatment of Arterial Hypertension BRAȘOVEANU, AM CRUCE, R MOGOANTĂ, L CÂRLIG, V Curr Health Sci J Original Paper Arterial hypertension is the leading cause of death worldwide and is one of the most important public health problems. Arterial hypertension is a major cardiovascular risk factor with an increasing incidence. In this paper we set out to analyze a group of 3050 patients hospitalized between January 2013 and December 2017 in terms of drug therapy. We found that the majority of patients received drug treatment with a converting-enzyme inhibitor as a monotherapy, and the most common drug association was the association between conversion enzyme inhibitor and calcium channel blocker. Medical University Publishing House Craiova 2019 2019-12-30 /pmc/articles/PMC7014987/ /pubmed/32110437 http://dx.doi.org/10.12865/CHSJ.45.04.03 Text en Copyright © 2019, Medical University Publishing House Craiova http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited.
spellingShingle Original Paper
BRAȘOVEANU, AM
CRUCE, R
MOGOANTĂ, L
CÂRLIG, V
The Treatment of Arterial Hypertension
title The Treatment of Arterial Hypertension
title_full The Treatment of Arterial Hypertension
title_fullStr The Treatment of Arterial Hypertension
title_full_unstemmed The Treatment of Arterial Hypertension
title_short The Treatment of Arterial Hypertension
title_sort treatment of arterial hypertension
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014987/
https://www.ncbi.nlm.nih.gov/pubmed/32110437
http://dx.doi.org/10.12865/CHSJ.45.04.03
work_keys_str_mv AT brasoveanuam thetreatmentofarterialhypertension
AT crucer thetreatmentofarterialhypertension
AT mogoantal thetreatmentofarterialhypertension
AT carligv thetreatmentofarterialhypertension
AT brasoveanuam treatmentofarterialhypertension
AT crucer treatmentofarterialhypertension
AT mogoantal treatmentofarterialhypertension
AT carligv treatmentofarterialhypertension